Table 4.
Differences in recognition and inhospital treatment of non-STEMIs between patients with COPD and non-COPD patients
| COPD N (%) |
Non-COPD N (%) |
Unadjusted OR (95% CI) | Minimally adjusted OR* (95% CI) | Adjusted OR (95% CI)† | |
|---|---|---|---|---|---|
| Inhospital treatment and diagnosis | |||||
| Initial diagnosis other than MI | 9551 (45.2) | 50 365 (35.5) | 1.50 (1.46 to 1.54) | 1.68 (1.64 to 1.73) | 1.46 (1.41 to 1.50) |
| Angiography in hospital | 8629 (40.9) | 74 304 (52.2) | 0.77 (0.76 to 0.79) | 0.63 (0.61 to 0.65) | 0.69 (0.66 to 0.71) |
| Discharge treatment | |||||
| Discharge on βblockers | 6632 (31.4) | 925 059 (64.9) | 0.25 (0.24 to 0.26) | 0.24 (0.23 to 0.25) | 0.25 (0.24 to 0.25) |
| Discharge on ACE inhibitor or angiotensin receptor blocker | 12 762 (60.4) | 89 368 (63.0) | 0.90 (0.87 to 0.92) | 0.91 (0.88 to 0.94) | 0.94 (0.91 to 0.97) |
| Discharge on aspirin | 15 234 (72.1) | 106 652 (75.1) | 0.86 (0.83 to 0.88) | 0.88 (0.85 to 0.91) | 0.91 (0.88 to 0.94) |
| Discharge on statin | 15 141 (71.7) | 104 804 (73.8) | 0.90 (0.87 to 0.93) | 0.90 (0.87 to 0.93) | 0.93 (0.90 to 0.96) |
| Discharge on thienopyridine | 11 277 (53.4) | 78 233 (55.1) | 0.93 (0.90 to 0.96) | 0.95 (0.91 to 0.98) | 0.97 (0.94 to 1.01) |
*Adjusted for age, sex smoking status and calendar year.†Adjusted for age, sex, smoking status, calendar year, drugs on admission and co-morbidities.
COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; STEMI, ST-elevation myocardial infarction.